Johnson Matthey PLC (LON:JMAT - Get Free Report) has been given an average rating of "Moderate Buy" by the six research firms that are presently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, three have given a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is GBX 2,010 ($25.02).
JMAT has been the subject of several research analyst reports. Berenberg Bank upped their price objective on shares of Johnson Matthey from GBX 1,650 ($20.54) to GBX 1,800 ($22.41) and gave the stock a "hold" rating in a report on Monday, April 8th. Numis Securities reaffirmed a "buy" rating and issued a GBX 2,200 ($27.39) price target on shares of Johnson Matthey in a research note on Wednesday, March 20th. Finally, Jefferies Financial Group reiterated a "buy" rating and issued a GBX 2,100 ($26.14) price objective on shares of Johnson Matthey in a report on Wednesday, March 20th.
View Our Latest Stock Analysis on JMAT
Johnson Matthey Stock Performance
LON JMAT traded up GBX 35 ($0.44) on Friday, hitting GBX 1,788 ($22.26). The stock had a trading volume of 248,998 shares, compared to its average volume of 689,053. The company's 50-day moving average is GBX 1,706.43 and its two-hundred day moving average is GBX 1,627.20. Johnson Matthey has a one year low of GBX 1,428.50 ($17.78) and a one year high of GBX 1,984 ($24.70). The stock has a market cap of £3.28 billion, a price-to-earnings ratio of 1,862.50, a P/E/G ratio of 49,242.50 and a beta of 0.98. The company has a quick ratio of 0.76, a current ratio of 1.51 and a debt-to-equity ratio of 63.95.
Insider Transactions at Johnson Matthey
In other Johnson Matthey news, insider Stephen Oxley acquired 24 shares of the firm's stock in a transaction on Wednesday, February 21st. The stock was purchased at an average cost of GBX 1,597 ($19.88) per share, for a total transaction of £383.28 ($477.13). Insiders acquired a total of 66 shares of company stock valued at $114,288 over the last quarter. Company insiders own 0.60% of the company's stock.
About Johnson Matthey
(
Get Free ReportJohnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
See Also
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
